Why the study?
Does implantation of paclitaxel-eluting stents compared with bare metal stents affect the percentage of uncovered stent struts in patients with STEMI?
Does implantation of paclitaxel-eluting stents compared with bare metal stents affect the percentage of uncovered stent struts in patients with STEMI?
In STEMI patients, paclitaxel-eluting stents reduce neointimal hyperplasia but result in higher rates of uncovered and malapposed stent struts at 13 months compared to bare metal stents.
No takes yet. Share an insight, caveat, or question.
PES increase uncovered struts at 13 months in STEMI versus BMS; extends randomized evidence of delayed healing with paclitaxel elution.
Guagliumi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: